Idexx Laboratories (0J8P) Share Forecast & Price Target
0J8P Analyst Ratings
0J8P Stock 12 Month Forecast
Average Price Target
$705.25▲(30.24% Upside)Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| Andrea Alfonso | UBS | $670→$627 | hold | 15.79%Upside | Assigned | 10/27/26 | ||
| Chris Schott | J.P. Morgan | $775→$750 | buy | 38.51%Upside | Assigned | 10/16/26 | ||
| Matthew Dellatorre | Goldman Sachs | $740 | buy | 36.66%Upside | Initiated | 10/15/26 | ||
| Scott Schoenhaus | KeyBanc | ― | hold | ― | Initiated | 10/12/26 | ||
| Ryan Daniels | William Blair | ― | buy | ― | Reiterated | 10/02/26 | ||
| Jonathan Block | Stifel Nicolaus | $675 | buy | 24.66%Upside | Reiterated | 08/14/26 | ||
| Michael Ryskin | Bank of America Securities | $660→$665 | hold | 22.81%Upside | Reiterated | 08/14/26 | ||
| Glen Santangelo | Barclays | $710 | buy | 31.12%Upside | Reiterated | 08/11/26 | ||
| Daniel Grosslight | Citi | $650→$670 | hold | 23.73%Upside | Reiterated | 08/05/26 | ||
| Erin Wright | Morgan Stanley | $805 | buy | 48.66%Upside | Reiterated | 08/05/26 | ||
| Keith Devas | Jefferies | $792 | buy | 46.26%Upside | Reiterated | 05/06/26 | ||
| David Westenberg | Piper Sandler | $775→$750 | hold | 38.51%Upside | Reiterated | 02/09/26 | ||
| Mark Massaro | BTIG | $830→$800 | buy | 47.74%Upside | Reiterated | 02/03/26 | ||
| Daniel Clark | Leerink Partners | $745→$785 | buy | 44.97%Upside | Reiterated | 11/03/25 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Andrea Alfonso | 10/27/26 | $670→$627 | hold | 15.79%Upside | Assigned | UBS | ||
| Chris Schott | 10/16/26 | $775→$750 | buy | 38.51%Upside | Assigned | J.P. Morgan | ||
| Matthew Dellatorre | 10/15/26 | $740 | buy | 36.66%Upside | Initiated | Goldman Sachs | ||
| Scott Schoenhaus | 10/12/26 | ― | hold | ― | Initiated | KeyBanc | ||
| Ryan Daniels | 10/02/26 | ― | buy | ― | Reiterated | William Blair | ||
| Jonathan Block | 08/14/26 | $675 | buy | 24.66%Upside | Reiterated | Stifel Nicolaus | ||
| Michael Ryskin | 08/14/26 | $660→$665 | hold | 22.81%Upside | Reiterated | Bank of America Securities | ||
| Glen Santangelo | 08/11/26 | $710 | buy | 31.12%Upside | Reiterated | Barclays | ||
| Daniel Grosslight | 08/05/26 | $650→$670 | hold | 23.73%Upside | Reiterated | Citi | ||
| Erin Wright | 08/05/26 | $805 | buy | 48.66%Upside | Reiterated | Morgan Stanley | ||
| Keith Devas | 05/06/26 | $792 | buy | 46.26%Upside | Reiterated | Jefferies | ||
| David Westenberg | 02/09/26 | $775→$750 | hold | 38.51%Upside | Reiterated | Piper Sandler | ||
| Mark Massaro | 02/03/26 | $830→$800 | buy | 47.74%Upside | Reiterated | BTIG | ||
| Daniel Clark | 11/03/25 | $745→$785 | buy | 44.97%Upside | Reiterated | Leerink Partners |
Best Analysts Covering Idexx Laboratories
Copying Daniel Clark's trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +7.60% per trade.
Copying Jonathan Block's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +24.85% per trade.
Copying Jonathan Block's trades and holding each position for 2 Years would result in 72.22% of your transactions generating a profit, with an average return of +54.21% per trade.
0J8P Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 5 | 6 | 7 | 7 | 8 |
| Hold | 5 | 3 | 5 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 10 | 9 | 12 | 13 | 14 |
In the current month, 0J8P has received 8 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. 0J8P average Analyst price target in the past 3 months is 705.25.
0J8P Financial Forecast
0J8P Earnings Forecast
Next quarter’s earnings estimate for 0J8P is $3.73 with a range of $3.64 to $3.82. The previous quarter’s EPS was $4.27. 0J8P beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0J8P has Performed in-line its overall industry.
0J8P Sales Forecast
Next quarter’s sales forecast for 0J8P is $1.19B with a range of $1.18B to $1.21B. The previous quarter’s sales results were $1.22B. 0J8P beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0J8P has Performed in-line its overall industry.